| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |